92 related articles for article (PubMed ID: 15347337)
1. Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern.
Smith KJ; Hamza S; Skelton H
Clin Exp Dermatol; 2004 Sep; 29(5):505-12. PubMed ID: 15347337
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod.
Michalopoulos P; Yawalkar N; Brönnimann M; Kappeler A; Braathen LR
Br J Dermatol; 2004 Oct; 151(4):903-6. PubMed ID: 15491436
[TBL] [Abstract][Full Text] [Related]
3. In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.
De Giorgi V; Salvini C; Chiarugi A; Paglierani M; Maio V; Nicoletti P; Santucci M; Carli P; Massi D
Int J Dermatol; 2009 Mar; 48(3):312-21. PubMed ID: 19261026
[TBL] [Abstract][Full Text] [Related]
4. The imidazoquinolines and their place in the therapy of cutaneous disease.
Smith KJ; Hamza S; Skelton H
Expert Opin Pharmacother; 2003 Jul; 4(7):1105-19. PubMed ID: 12831337
[TBL] [Abstract][Full Text] [Related]
5. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
Vidal D; Matías-Guiu X; Alomar A
Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
[TBL] [Abstract][Full Text] [Related]
6. Activation and transcriptional profile of monocytes and CD8
Gudd CLC; Au L; Triantafyllou E; Shum B; Liu T; Nathwani R; Kumar N; Mukherjee S; Dhar A; Woollard KJ; Yone Y; Pinato DJ; Thursz MR; Goldin RD; Gore ME; Larkin J; Khamri W; Antoniades CG; Turajlic S; Possamai LA
J Hepatol; 2021 Jul; 75(1):177-189. PubMed ID: 33631227
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.
Huang SJ; Hijnen D; Murphy GF; Kupper TS; Calarese AW; Mollet IG; Schanbacher CF; Miller DM; Schmults CD; Clark RA
J Invest Dermatol; 2009 Nov; 129(11):2676-85. PubMed ID: 19516264
[TBL] [Abstract][Full Text] [Related]
9. Streptococcus salivarius-mediated CD8
Wang J; Yang L; Mao X; Li Z; Lin X; Jiang C
Exp Cell Res; 2018 May; 366(2):121-126. PubMed ID: 29530474
[TBL] [Abstract][Full Text] [Related]
10. Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment.
Wolf IH; Kodama K; Cerroni L; Kerl H
Am J Dermatopathol; 2007 Jun; 29(3):237-41. PubMed ID: 17519620
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
[TBL] [Abstract][Full Text] [Related]
12. Prolonged imiquimod treatment and graft-versus-host reaction: histological mimicry in the skin infiltration pattern of the monocyte-macrophage-dendrocyte lineage.
Hermanns-Lê T; Paquet P; Nikkels AF; Piérard-Franchimont C; Piérard GE
Dermatology; 2003; 206(4):361-5. PubMed ID: 12771487
[TBL] [Abstract][Full Text] [Related]
13. Lichen sclerosus: evidence that immunological changes occur at all levels of the skin.
Farrell AM; Marren P; Dean D; Wojnarowska F
Br J Dermatol; 1999 Jun; 140(6):1087-92. PubMed ID: 10354075
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment.
Simon D; Vassina E; Yousefi S; Braathen LR; Simon HU
Allergy; 2005 Jul; 60(7):944-51. PubMed ID: 15932386
[TBL] [Abstract][Full Text] [Related]
15. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
[TBL] [Abstract][Full Text] [Related]
16. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
17. The treatment of viral infections and nonmelanoma skin cancers.
Del Rosso JQ
Cutis; 2007 Apr; 79(4 Suppl):29-35. PubMed ID: 17508493
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of invasive squamous cell carcinoma using topical imiquimod.
Hengge UR; Schaller J
Arch Dermatol; 2004 Apr; 140(4):404-6. PubMed ID: 15096367
[No Abstract] [Full Text] [Related]
19. Invasive squamous cell carcinoma treated with imiquimod 5% cream.
Flórez A; Feal C; de la Torre C; Cruces M
Acta Derm Venereol; 2004; 84(3):227-8. PubMed ID: 15202841
[No Abstract] [Full Text] [Related]
20. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio.
Azzimonti B; Zavattaro E; Provasi M; Vidali M; Conca A; Catalano E; Rimondini L; Colombo E; Valente G
Br J Dermatol; 2015 Jan; 172(1):64-73. PubMed ID: 24910265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
